Clomiphene citrate for male infertility: A systematic review and meta‐analysis
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Background: Male infertility is a prevalent and worldwide problem with various difficulties in treatment. Clomiphene citrate is a selective estrogen receptor modulator and may improve semen quality by stimulating hormone synthesis and spermatogenesis. There is lack of evidence on the efficacy of clomiphene citrate as therapy for male infertility. Objectives: Therefore, a systematic review and meta‐analysis was performed to assess the efficacy of clomiphene citrate on sperm quality in infertile men. Methods: A search was conducted in the PubMed, EMBASE and Cochrane databases for effectiveness in infertile males treated with clomiphene citrate. Both intervention and observational studies were included. Primary outcome measures were semen parameters (concentration, motility and morphology). Secondary outcomes included hormonal evaluation, pregnancy rate and side effects. Studies were included for meta‐analysis if they provided absolute numbers for outcomes before and during treatment with appropriate SD or SE. Results: Total 1799 studies were identified during the search, 18 studies remained for qualitative analysis (n = 731) and 15 studies for meta‐analysis (n = 566). Study populations ranged between 11 and 140 participants. Sperm concentration was higher during treatment, with a mean difference 8.38 × 10 6/ml (95% confidence interval: 5.17–11.59; p < 0.00001; I2 = 87%). Total sperm motility was higher during treatment, with a mean difference of 8.14% (95% confidence interval: 3.83–12.45; p < 0.00001; I2 = 76%). There was no difference in sperm morphology before and during treatment. Total testosterone, follicle‐stimulating hormone, luteinizing hormone and estradiol were higher during clomiphene citrate treatment. During follow‐up, no serious adverse effects occurred. In 10 studies, pregnancy rate was reported and yielded a mean of 17% during clomiphene citrate treatment (range: 0%–40%). Conclusions: Clomiphene citrate increased sperm concentration and motility and could be considered as a safe therapy for improving sperm parameters in infertile males.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evaluating non-randomised intervention studies
Deeks, J., Dinnes, J., D'Amico, R., Sowden, A., Sakarovitch, C., Song, F., Petticrew, M., & Altman, D. (2003) · Health Technology Assessment · doi:10.3310/hta7270 · Cited by 2,907
Thomas, B. H., Ciliska, D., Dobbins, M., & Micucci, S. (2004) · Worldviews on Evidence-Based Nursing · doi:10.1111/j.1524-475x.2004.04006.x · Cited by 2,118
The International Glossary on Infertility and Fertility Care, 2017
Zegers-Hochschild, F., Adamson, G. D., Dyer, S., Racowsky, C., de Mouzon, J., Sokol, R., Rienzi, L., Sunde, A., Schmidt, L., Cooke, I. D., et al. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.06.005 · Cited by 1,505
The international glossary on infertility and fertility care, 2017
Zegers-Hochschild, F., Adamson, G. D., Dyer, S., Racowsky, C., de Mouzon, J., Sokol, R., Rienzi, L., Sunde, A., Schmidt, L., Cooke, I. D., et al. (2017) · Human Reproduction · doi:10.1093/humrep/dex234 · Cited by 1,320
Criteria for the systematic review of health promotion and public health interventions
Jackson, N., & Waters, E. (2005) · Health Promotion International · doi:10.1093/heapro/dai022 · Cited by 572
The Sixth Edition of the WHO Manual for Human Semen Analysis: A Critical Review and SWOT Analysis
Boitrelle, F., Shah, R., Saleh, R., Henkel, R., Kandil, H., Chung, E., Vogiatzi, P., Zini, A., Arafa, M., & Agarwal, A. (2021) · Life · doi:10.3390/life11121368 · Cited by 271
Chua, M. E., Escusa, K. G., Luna, S., Tapia, L. C., Dofitas, B., & Morales, M. (2013) · Andrology · doi:10.1111/j.2047-2927.2013.00107.x · Cited by 183
Helo, S., Ellen, J., Mechlin, C., Feustel, P., Grossman, M., Ditkoff, E., & McCullough, A. (2015) · The Journal of Sexual Medicine · doi:10.1111/jsm.12944 · Cited by 102
Clomiphene citrate for men with hypogonadism: a systematic review and meta‐analysis
Huijben, M., Lock, M. T. W. T., de Kemp, V. F., de Kort, L. M. O., & van Breda, H. M. K. (2022) · Andrology · doi:10.1111/andr.13146 · Cited by 65
Self-citationLong-Term Safety and Efficacy of Clomiphene Citrate for the Treatment of Hypogonadism
Krzastek, S. C., Sharma, D., Abdullah, N., Sultan, M., Machen, G. L., Wenzel, J. L., Ells, A., Chen, X., Kavoussi, M., Costabile, R. A., et al. (2019) · Journal of Urology · doi:10.1097/ju.0000000000000396 · Cited by 52
Predicting Biochemical Response to Clomiphene Citrate in Men with Hypogonadism
Mazzola, C. R., Katz, D. J., Loghmanieh, N., Nelson, C. J., & Mulhall, J. P. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12592 · Cited by 50 · cited 1×
“So no conclusion can be drawn from these results with respect to fertility.25 In contrast for the CC effect on hypogonadism, the study by Mazzola et al. (2014) reported that low LH (<6 miU/ml) and a testis volume greater than 14 cm3 were predictors of a better biochemical response to CC therapy in…”
Wheeler, K. M., Smith, R. P., Kumar, R. A., Setia, S., Costabile, R. A., & Kavoussi, P. K. (2017) · Journal of Urology · doi:10.1016/j.juro.2016.10.068 · Cited by 47
Research works printed but not linked: 37
- 10.1093/humrep/dem046 · DOI · Paper page
- 10.1371/journal.pmed.1001356 · DOI · Paper page
- 10.1093/oxfordjournals.humrep.a137433 · DOI · Paper page
- 10.1016/j.fertnstert.2014.12.122 · DOI
- 10.1517/14656566.2014.913022 · DOI · Paper page
- 10.1016/S0015-0282(16)34082-1 · DOI
- 10.1016/j.juro.2011.10.137 · DOI · Paper page
- 10.1016/j.xfre.2020.04.003 · DOI
- 10.1016/j.jclinepi.2004.06.001 · DOI
- Review Manager (RevMan). Version 5.4.The Cochrane Collaboration;2020.
- 10.1186/1471-2288-5-13 · DOI · Paper page
- Higgins J, 2011, Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0
- 10.1016/S0022-5347(17)55290-8 · DOI
- 10.1111/j.1365-2605.1980.tb00136.x · DOI · Paper page
- 10.1111/j.1442-2042.1998.tb00367.x · DOI
- Moradi M, 2010, Safety and efficacy of clomiphene citrate and L‐carnitine in idiopathic male infertility: a comparative study, Urol J, 7, 188
- 10.1111/andr.12086 · DOI
- 10.1038/ijir.2015.21 · DOI
- 10.1111/and.13257 · DOI
- 10.1016/j.ejogrb.2019.05.011 · DOI
- 10.1111/and.14399 · DOI
- 10.1111/j.1439-0272.1981.tb00072.x · doi:10.1111/j.1439-0272.1981.tb00072.x
- 10.1016/S0015‐0282(16)47300‐0 · DOI
- 10.1016/S0015-0282(16)48685-1 · DOI
- 10.1016/S0022-5347(17)48889-6 · DOI · Paper page
- 10.1016/S0015-0282(16)60319-9 · DOI
- 10.1016/S0015-0282(16)59898-7 · DOI
- 10.1111/j.1365-2605.1992.tb01129.x · DOI · Paper page
- 10.3109/01485019608987099 · DOI
- National Collaborating Centre for Women's and Children's Health (UK).Fertility: assessment and treatment for people with fertility problems. In:National Institute for Health and Care Excellence: Guidelines.RCOG Press;2013. Accessed July 9 2021.www.cla.co.uk
- 10.1016/j.juro.2006.06.006 · DOI · Paper page
- 10.1111/j.1464-410X.1982.tb13647.x · DOI · Paper page
- Matthews GJ, 1995, Nonbacterial pyospermia: a consequence of clomiphene citrate therapy, Int J Fertil Menopausal Stud, 40, 187
- 10.1016/j.fertnstert.2008.03.036 · DOI
- Opsahl MS, 1996, Single vs. multiple semen specimens in screening for male infertility factors. A comparison, J Reprod Med, 41, 313
- 10.1016/S0022-5347(17)47294-6 · DOI
- 10.1016/j.fertnstert.2015.10.027 · DOI · Paper page
Metadata
- Authors
- Huijben, M., Huijsmans, R. L. N., Lock, M. T. W. T., de Kemp, V. F., de Kort, L. M. O., & van Breda, J. H. M. K.
- Venue
- Andrology
- Publisher
- Wiley
- Published
- 2023-01-29
- Volume
- 11
- Issue
- 6
- Pages
- 987-996
- ISSN
- 2047-2919
- 2047-2927
- Cited by
- 72
- References
- 12
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.